Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

DHT is a strong androgen that may pose less risk to the prostate compared to testosterone.

Lower ghrelin levels and certain gene variations may increase acne risk.

Higher androgen levels are linked to more severe hair growth in hirsute women.

Androgens like testosterone affect skin health and can lead to conditions such as acne and hair loss, with various treatments available.

Evaluate postmenopausal women with high androgen levels using medical history, physical exams, lab tests, and imaging to manage health risks.

Surgery to lower high testosterone in postmenopausal women with certain ovarian tumors doesn't significantly affect their metabolism.

Androgens can both increase and decrease hair growth in different parts of the body.

Androgens can cause hair growth in some areas and hair loss on the scalp.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

CB-03-01 is a promising skin cream for treating hormone-related skin problems without causing harmful body-wide effects.

Androstenedione is better than testosterone for diagnosing PCOS in Indian women.

Using a protocol with LH improves pregnancy rates in patients with low ovarian reserve.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Androgens affect bone and fat cell development differently based on the cells' embryonic origin.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Brain-Derived Neurotrophic Factor (BDNF) slows down hair growth and promotes hair follicle regression.

Exercise, especially vigorous aerobic and resistance training, can improve hormone levels in women with PCOS.

Finasteride doesn't affect hormone levels in normal men.

New treatments for male hypogonadism are effective and should be personalized.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Women with PCOS may have a higher risk of respiratory and ear infections due to slower nasal mucociliary clearance.

Women with PCOS had higher SRAGE levels, possibly linked to BMI, not PCOS.